Nanoscope Technologies is Biotechnology in United States that focus on biomedical technologies business. Founded in 2009. They cover business area such as operator, new method, device, scientific, industrial and biomedical application, diagnostic, molecule, optical gene delivery, functional imaging, neuromodulation, optical manipulation, medical researcher, next generation biomedical stimulation, imaging platform.
2009
( 15 years old in 2024 )
Biomedical Technologies
-
1312 Brown Trail
Bedford, TX 76022
United States
Private
operatornew methoddevicescientific, industrial and biomedical applicationdiagnosticmoleculeoptical gene deliveryfunctional imagingneuromodulationoptical manipulationmedical researchernext generation biomedical stimulationimaging platform
* We use standard office opening hours in near Nanoscope Technologies's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Nanoscope Technologies is Biotechnology business from United States that founded in 2009 (15 years old in 2024), Nanoscope Technologies business is focusing on Biomedical Technologies.
Nanoscope Technologies headquarter office and corporate office address is located in 1312 Brown Trail Bedford, TX 76022 United States.
Nanoscope Technologies was founded in United States.
In 2024, Nanoscope Technologies is currently focus on biomedical technologies sector.
Above is snippet of Google Trends for "biomedical technologies" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Nanoscope Technologies, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
